Study identifies interaction site for serotonin type 3A and RIC-3 chaperone
To address the receptor dysfunction associated with several serious neurological diseases, Michaela Jansen, Pharm.D., Ph.D., from the Texas Tech University Health Sciences Center School of Medicine recently completed a study ...